Yüklüyor......
Role of oral teriflunomide in the management of multiple sclerosis
The landscape of the treatment of relapsing–remitting multiple sclerosis is changing fast. Several oral treatments have shown benefit and generate much interest because of the convenience of their administration. Two oral compounds, fingolimod and teriflunomide, have been approved in relapsing–remit...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3639219/ https://ncbi.nlm.nih.gov/pubmed/23637535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S31248 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|